Gold prices hold losses as US-EU trade deal eases safe‑haven demand
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE:A) reported better-than-expected first-quarter earnings and revenue but saw its shares tumble 4.8% after hours as the company’s full-year guidance fell short of analyst expectations.
The scientific instrument maker posted adjusted earnings per share of $1.31 for the quarter ended January 31, beating the analyst consensus of $1.27. Revenue came in at $1.68 billion, slightly above estimates of $1.67 billion and up 1.2% YoY on a core basis.
Despite the Q1 beat, Agilent’s outlook for fiscal 2025 disappointed investors. The company forecasts full-year revenue of $6.68 billion to $6.76 billion, below the $6.82 billion analysts were expecting. Adjusted EPS guidance of $5.54 to $5.61 also fell short of the $5.57 consensus at the midpoint.
"The Agilent team delivered better than our expectations in Q1. As a result of a solid start to the year, we’re maintaining our core growth and EPS expectations for the year," said Agilent President and CEO Padraig McDonnell.
For the second quarter, Agilent projects revenue of $1.61 billion to $1.65 billion, representing 2.5% to 5% core growth. Q2 adjusted EPS is expected between $1.25 and $1.28.
The company’s Life Sciences and Diagnostics Markets Group saw 1% core growth in Q1, while the Agilent CrossLab Group grew 3%. The Applied Markets Group declined 2% on a core basis.
Agilent maintained its full-year core revenue growth outlook of 2.5% to 3.5% despite lowering its reported growth forecast. The company cited early benefits from its new market-first strategy and transformation initiatives aimed at improving agility.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.